149 related articles for article (PubMed ID: 15901794)
1. (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Ni W; Wilhelm CS; Bader M; Murphy DL; Lookingland K; Watts SW
J Pharmacol Exp Ther; 2005 Sep; 314(3):953-60. PubMed ID: 15901794
[TBL] [Abstract][Full Text] [Related]
2. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Ni W; Li MW; Thakali K; Fink GD; Watts SW
J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
[TBL] [Abstract][Full Text] [Related]
3. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.
Ni W; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 May; 321(2):485-91. PubMed ID: 17289838
[TBL] [Abstract][Full Text] [Related]
4. The serotonin transporter is present and functional in peripheral arterial smooth muscle.
Ni W; Thompson JM; Northcott CA; Lookingland K; Watts SW
J Cardiovasc Pharmacol; 2004 Jun; 43(6):770-81. PubMed ID: 15167270
[TBL] [Abstract][Full Text] [Related]
5. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Johnson GJ; Leis LA; Dunlop PC; Weir EK
J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos.
Amireault P; Dubé F
Biol Reprod; 2005 Aug; 73(2):358-65. PubMed ID: 15858217
[TBL] [Abstract][Full Text] [Related]
7. Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin.
Kumar RK; Darios ES; Burnett R; Thompson JM; Watts SW
Pharmacol Res; 2019 Feb; 140():43-49. PubMed ID: 30189295
[TBL] [Abstract][Full Text] [Related]
8. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
[TBL] [Abstract][Full Text] [Related]
9. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
Gobbi G; Murphy DL; Lesch K; Blier P
J Pharmacol Exp Ther; 2001 Mar; 296(3):987-95. PubMed ID: 11181933
[TBL] [Abstract][Full Text] [Related]
10. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Marcos E; Adnot S; Pham MH; Nosjean A; Raffestin B; Hamon M; Eddahibi S
Am J Respir Crit Care Med; 2003 Aug; 168(4):487-93. PubMed ID: 12773327
[TBL] [Abstract][Full Text] [Related]
11. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
Eddahibi S; Hanoun N; Lanfumey L; Lesch KP; Raffestin B; Hamon M; Adnot S
J Clin Invest; 2000 Jun; 105(11):1555-62. PubMed ID: 10841514
[TBL] [Abstract][Full Text] [Related]
12. A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction.
Ogden K; Thompson JM; Hickner Z; Huang T; Tang DD; Watts SW
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2857-63. PubMed ID: 16861698
[TBL] [Abstract][Full Text] [Related]
13. Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.
Linder AE; Diaz J; Ni W; Szasz T; Burnett R; Watts SW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1745-52. PubMed ID: 18263707
[TBL] [Abstract][Full Text] [Related]
14. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
Callaway CW; Wing LL; Nichols DE; Geyer MA
Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice.
Montañez S; Owens WA; Gould GG; Murphy DL; Daws LC
J Neurochem; 2003 Jul; 86(1):210-9. PubMed ID: 12807440
[TBL] [Abstract][Full Text] [Related]
16. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.
Welch JT; Lim DS
Bioorg Med Chem; 2007 Nov; 15(21):6659-66. PubMed ID: 17765553
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine.
Gruetter CA; Lemke SM; Anestis DK; Szarek JL; Valentovic MA
Eur J Pharmacol; 1992 Jul; 217(2-3):109-18. PubMed ID: 1358631
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
Russell A; Banes A; Berlin H; Fink GD; Watts SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
[TBL] [Abstract][Full Text] [Related]
20. Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
Vickers SP; Dourish CT; Kennett GA
Neuropharmacology; 2001 Aug; 41(2):200-9. PubMed ID: 11489456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
